INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. Use additional sheet(s) if necessary.

1. Company Name and Address4. EPA ProductRegistration

United States Environmental Protection

Agency Washington, D.C. 20460

DATA CALL-IN RESPONSE

3. Date and Type of DCI 

GENERIC17-Mar-2010ID # GDCI-03560

2. Case # and Name

2135 Dazomet, and saltsChemical # and Name 035602

Dazomet

5. I wish to cancel this product registration voluntarily

6. Generic Data 7. Product Specific Data

7a. My product is an MUP andI agree to satisfy the MUP requirements on the attached form entitled "Requirements Status and Registrant's Response."

6a. I am claiming a GenericData Exemption because I obtain the active ingredient from the source EPA registration number listed below.

6b. I agree to satisfy Generic Data requirements as indicated on the attached form entitled "Requirements Status and Registrant's Response."

N.A. 

10. Name of Company 11. Phone Numb

9. Date 8. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that any knowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law.

Signature and Title of Company's Authorized Representative__________________________________
Dazomet

INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. Use additional sheet(s) if necessary.

4. Guideline Requirement Number

5. Study Title

1. Company Name and Address

United States Environmental Protection

Agency Washington, D.C. 20460

REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE

3. Date and Type of DC

ID #GENERIC17-Mar-2010

GDCI-03560

2. Case # and Name

2135 Dazomet, and salts

Chemical # and Name 035602

7. Test Substance

6. Use Pattern

P

R

O

T

O

C

O

L

Progress

Reports

1 2 3

Applicator Exposure Data Requirements (Antimicrobial)

875.1200 Dermal exposure--Indoor (7 ,8) BB, GG, Y, X, FF, Z 875.1400 Inhalation exposure--indoor (9 ,10 ,11) BB, GG, Y, X, FF, Z 875.1600 Application exposure monitoring data reporting (12) BB, GG, Y, X, FF, Z 875.1700 Product Use Information (34 ,35) BB, GG, Y, X, FF, Z 

Post-Application Exposure Data Requirements (ConventionalChemical)

875.2500 Inhalation exposure (1 ,13 ,14) BB, GG, Y, X, FF, Z 875.2900 Data reporting and calculations (2) BB, GG, Y, X, FF, Z 

Postapplication Exposure Data Requirements (Antimicrobial)

875.2800 Description of human activity (15) BB, GG, Y, X, FF, Z 875.2700 Product Use Information (3) BB, GG, Y, X, FF, Z 

Product Chemistry Data Requirements (Antimicrobial)

12. Name of Company 13. Phone NumbSignature and Title of Company's Authorized Representative__________________________________10. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that any knowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law

11. Date
Dazomet

INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. Use additional sheet(s) if necessary.

4. Guideline Requirement Number

5. Study Title

1. Company Name and Address

United States Environmental Protection

Agency Washington, D.C. 20460

REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE

3. Date and Type of DC

ID #GENERIC17-Mar-2010

GDCI-03560

2. Case # and Name

2135 Dazomet, and salts

Chemical # and Name 035602

7. Test Substance

6. Use Pattern

P

R

O

T

O

C

O

L

Progress

Reports

1 2 3

830.7050 UV/Visible absorption (21) BB, GG, Y, X, FF, Z TGAI & Degr 

Residue Chemistry Data Requirements (Antimicrobial)

860.1520 Processed food/feed(FOOD COMMODITIES) (6) BB, GG, Y, X, FF, Z TEP & Met 

Terrestrial and Aquatic Nontarget Organisms DataRequirements (Antimicrobial)

850.1025 Oyster acute toxicity test (shell deposition) (18) BB, GG, Y, X, FF, Z DEGR 850.1035 Mysid acute toxicity test (19) BB, GG, Y, X, FF, Z DEGR 850.1075 Fish acute toxicity test, freshwater and marine (16 ,17) BB, GG, Y, X, FF, Z DEGR 

Toxicology Data Requirements (Antimicrobial)

870.3700 Prenatal developmental toxicity study (24 ,25) BB, GG, Y, X, FF, Z DEGR 870.3800 Reproduction and fertility effects (26 ,27 ,28) BB, GG, Y, X, FF, Z DEGR 870.4200 Carcinogenicity (32 ,33) BB, GG, Y, X, FF, Z DEGR 870.5395 Mammalian erythrocyte micronucleus test (29 ,30 ,31) BB, GG, Y, X, FF, Z DEGR 

Initial to indicate certification as to information on this page (fulltext of certification is on page one).

Date
Dazomet

INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. Use additional sheet(s) if necessary.

4. Guideline Requirement Number

5. Study Title

1. Company Name and Address

United States Environmental Protection

Agency Washington, D.C. 20460

REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE

3. Date and Type of DC

ID #GENERIC17-Mar-2010

GDCI-03560

2. Case # and Name

2135 Dazomet, and salts

Chemical # and Name 035602

7. Test Substance

6. Use Pattern

P

R

O

T

O

C

O

L

Progress

Reports

1 2 3

870.6200 Neurotoxicity screening battery (22 ,23) BB, GG, Y, X, FF, Z DEGR 870.7800 Immunotoxicity (20) BB, GG, Y, X, FF, Z DEGR 850.2100 Avian acute oral toxicity test (4 ,5) BB, GG, Y, X, FF, Z DEGR 

Initial to indicate certification as to information on this page (fulltext of certification is on page one).

Date
Case # and Name: 2135 Dazomet, and salts

DCI Number: GDCI-035602-29024

Footnotes: [The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Key:

United States Environmental Protection

Agency Washington, D.C. 20460

FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTS

TEP & Met = Typical End-Use Product and Metabolites; TGAI & Degr = Technical Grade of the Active Ingredient and Degration Product; DEGR = Degradant [D

Use Categories Key:

X - Y - Z - 

Materials preservativesIndustrial processes and water s

Industrial processes and water s

BB - FF - GG - 

Wood preservativesHigh Exposure AntimicrobialLow Exposure Antimicrobial

1 Data required on MITC.2 Post-application data reporting calculations are required on MITC.3 Data are required describing how dazomet is actually used and applied, including information on post-application entry restrictions, re-entry intervals, rin

and other use data relevant to exposure after application.

4 Data are required on one passerine species and either one waterfowl species or one upland game bird species for terrestrial, aquatic, forestry, and resid

on waterfowl or upland game bird species for indoor and greenhouse uses.

5 Study required with MITC.6 Confirmatory food contact paper residue data are required on dazomet and MITC in support of antimicrobial uses.7 Biological monitoring data may be submitted in addition to, or in lieu of, dermal and inhalation exposure data, provided the human pharmocokinetics of th

compounds (i.e., whichever method is selected as an indicator of body burden or internal dose) allow for the back calculation to actual dose.

8 Protocols must be submitted for approval prior to the initiation of the study. Details for developing protocols are available from the Agency.

9 Data required on dazomet.10 Protocols must be submitted for approval prior to the initiation of the study. Details for developing protocols are available from the Agency.

11 Biological monitoring data may be submitted in addition to, or in lieu of, dermal and inhalation exposure data, provided the human pharmocokinetics of th

compounds (i.e., whichever method is selected as an indicator of body burden or internal dose) allow for the back calculation to actual dose.

12 Data required on dazomet.13 Protocols must be submitted for approval prior to the initiation of the study. Details for developing protocols are available from the Agency.

14 Biological monitoring data may be submitted in addition to, or in lieu of, dermal and inhalation exposure data, provided the human pharmocokinetics of th

compounds (i.e., whichever method is selected as an indicator of body burden or internal dose) allow for the back calculation to actual dose.

15 Data on worker application parameters are required.
Case # and Name: 2135 Dazomet, and salts

DCI Number: GDCI-035602-29024

Footnotes: [The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Key:

United States Environmental Protection

Agency Washington, D.C. 20460

FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTS

TEP & Met = Typical End-Use Product and Metabolites; TGAI & Degr = Technical Grade of the Active Ingredient and Degration Product; DEGR = Degradant [D

16 Study required only on estuarine/marine fish.17 Study required with MITC.18 Study required with MITC.19 Study required with MITC.20 Study required with MITC.21 Study required with dazomet and MITC.22 Acute neurotoxicity study required in rat via the inhalation route with pathological evaluation of the complete respiratory tract.

23 Study required with MITC.24 Inhalation reproductive and developmental toxicity screening study in rats and rabbits is required.25 Study required with MITC.26 The use of a combined study that utilizes the 2-generation addition of other endpoints or functional assessments in the immature animal is encouraged.

27 Two generation reproduction study in rats via inhalation with gross and histopathological evaluation of the complete respiratory tract in offspring is requir

discussing with the registrant the potential for performing the new enhanced one-generation reproductive study instead of the standard two-generation s

28 Study required with MITC.29 The micronucleus rodent bone marrow assay is preferred; however, rodent bone marrow assays using metaphase analysis (aberrations) are acceptable30 At a minimum, an initial battery of mutagenicity tests with possible confirmatory testing is required. Other relevant mutagenicity tests that may have been 

list must also be submitted.
Case # and Name: 2135 Dazomet, and salts

DCI Number: GDCI-035602-29024

Footnotes: [The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Key:

United States Environmental Protection

Agency Washington, D.C. 20460

FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTS

TEP & Met = Typical End-Use Product and Metabolites; TGAI & Degr = Technical Grade of the Active Ingredient and Degration Product; DEGR = Degradant [D

31 Study required with MITC.32 Chronic inhalation carcinogenicity and toxicity studies in rats and mice is required.33 Study required with MITC.34 Data required to describe how the pesticide is actually used and applied, including information on use and reapplication rates, frequency of use, and othe

application.

35 Data required on dazomet.
United States Environmental Protection

Agency Washington, D.C. 20460

LIST OF ALL REGISTRANTS SENT THIS DATA CALL-IN NOTICE

Co. Nr. Company Name Agent For Address City & S

Case # and Name: 2135,Dazomet, and salts

BASF CORPORATION PO Box 13528 26 DAVIS DRIVE RESEAR

TRIANG

7969 1448 BUCKMAN LABORATORIES INC. 1256 NORTH MCLEAN BLVD MEMPH70051 CERTIS USA, LLC 9145 GUILFORD ROAD, SUITE 175 COLUM67869 VERICHEM, INC. 3499 GRAND AVENUE PITTSB9386 KEMIRA CHEMICALS, INC, 1950 VAUGHAN ROAD KENNES